A detailed history of Arnhold LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Arnhold LLC holds 22,952 shares of GILD stock, worth $2.12 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
22,952
Previous 22,952 -0.0%
Holding current value
$2.12 Million
Previous $1.57 Million 22.17%
% of portfolio
0.2%
Previous 0.17%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$73.27 - $83.09 $20,442 - $23,182
-279 Reduced 1.2%
22,952 $1.86 Million
Q2 2023

Aug 08, 2023

SELL
$76.01 - $86.7 $228 - $260
-3 Reduced 0.01%
23,231 $1.79 Million
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $1,778 - $2,025
23 Added 0.1%
23,234 $1.93 Million
Q3 2022

Oct 27, 2022

BUY
$59.54 - $68.01 $893 - $1,020
15 Added 0.06%
23,211 $1.43 Million
Q2 2022

Jul 26, 2022

BUY
$57.72 - $65.01 $8,773 - $9,881
152 Added 0.66%
23,196 $1.43 Million
Q1 2022

May 10, 2022

BUY
$57.92 - $72.58 $1.33 Million - $1.67 Million
23,044 New
23,044 $1.37 Million
Q1 2020

Apr 17, 2020

SELL
$62.63 - $80.22 $12 Million - $15.4 Million
-191,588 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$61.62 - $67.78 $1.21 Million - $1.33 Million
19,614 Added 11.41%
191,588 $12.4 Million
Q3 2019

Oct 29, 2019

BUY
$62.51 - $69.0 $126,082 - $139,173
2,017 Added 1.19%
171,974 $10.9 Million
Q2 2019

Aug 08, 2019

BUY
$61.87 - $69.38 $1.8 Million - $2.01 Million
29,028 Added 20.6%
169,957 $11.5 Million
Q1 2019

May 09, 2019

BUY
$62.53 - $70.05 $1.02 Million - $1.15 Million
16,352 Added 13.13%
140,929 $9.16 Million
Q4 2018

Feb 08, 2019

BUY
$60.54 - $79.0 $48,008 - $62,647
793 Added 0.64%
124,577 $7.79 Million
Q3 2018

Nov 06, 2018

BUY
$71.28 - $78.92 $63,011 - $69,765
884 Added 0.72%
123,784 $9.56 Million
Q2 2018

Aug 14, 2018

BUY
$64.88 - $75.68 $1.3 Million - $1.51 Million
20,000 Added 19.44%
122,900 $8.71 Million
Q1 2018

May 11, 2018

BUY
$72.84 - $88.8 $7.5 Million - $9.14 Million
102,900 New
102,900 $7.76 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Arnhold LLC Portfolio

Follow Arnhold LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arnhold LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arnhold LLC with notifications on news.